Rare diseases
Investigational molecules
Locations
Back to Slovakia49 clinical trials in Nove Zamky, Slovakia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SlovakiaKlinickeSkusky.sk(opens in a new tab)Study on the Effectiveness of Abelacimab for High-Risk Atrial Fibrillation Patients Unsuitable for Oral Anticoagulation
SlovakiaA Phase 3b Study of Guselkumab Compared with Risankizumab in Adults with Moderately to Severely Active Crohn’s Disease
SlovakiaA study to evaluate the efficacy and safety of eloralintide in adults with obesity or overweight and type 2 diabetes
SlovakiaA Study Comparing PF-08046054 to Docetaxel in Adults with Previously Treated PD-L1 Positive Non-Small Cell Lung Cancer
SlovakiaStudy of PF-07248144 and fulvestrant in adults with hormone receptor-positive, HER2-negative advanced or metastatic breast cancer who had progression after CDK4/6 inhibitor therapy
SlovakiaEvaluating the Effect of Vicadrostat and Empagliflozin Combination Compared to Empagliflozin Alone in Patients with Heart Failure and Reduced Left Ventricular Function
SlovakiaStudy of Sigvotatug Vedotin and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer with High PD-L1 Levels
SlovakiaStudy on Long-term Safety of Zasocitinib for Adults with Moderate to Severe Ulcerative Colitis and Crohn's Disease
SlovakiaStudy on the Effectiveness and Safety of RO7790121 for Patients with Moderate to Severe Crohn's Disease
SlovakiaStudy of Nipocalimab or IVIG for Pregnant Women at Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)
SlovakiaSlovakiaStudy on the Effects of Zasocitinib for Patients with Moderate to Severe Crohn's Disease
SlovakiaThe busiest research cities in the country
What the registry says about research in the country
Clinical investigations focusing on non-small cell lung cancer and advanced breast cancer treatments, including studies of innovative therapies for patients with metastatic conditions. Research includes evaluation of novel drug combinations and targeted treatments.
Comprehensive studies of treatments for inflammatory bowel diseases, including Crohn's Disease and Ulcerative Colitis. Additional research covers dermatological conditions like atopic dermatitis and hidradenitis suppurativa.
Studies focusing on cardiovascular disease prevention and treatment, including research on stroke prevention, heart failure management, and atherosclerotic cardiovascular disease interventions.
Research initiatives targeting Type 2 diabetes, obesity, and metabolic conditions. Studies evaluate new therapeutic approaches and their impact on cardiovascular outcomes in patients with metabolic disorders.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
